CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Legal Officer sold 14,261 shares at $16.66 ($237,618)
- 4 Exercise or conversion Chief Scientific Officer acquired 31,333 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 3,661 shares at an average $16.60 ($60,767)
- 4 Open-market sale Chief Legal Officer sold 4,421 shares at an average $16.60 ($73,381)
- 4 Open-market sale Chief Scientific Officer sold 4,895 shares at an average $16.60 ($81,249)
- 4 Planned sale Chief Legal Officer sold 3,760 shares at $18.42 ($69,273)
- 4 Planned sale Chief Legal Officer sold 3,760 shares at an average $17.90 ($67,314)
- 4 Planned sale Chief Legal Officer sold 37,600 shares at $17.07 ($641,697)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 6,284 shares at $12.56 ($78,931)
- 4 Open-market sale Chief Financial Officer sold 3,130 shares at $12.80 ($40,054)
- 4 Open-market sale Chief Legal Officer sold 3,644 shares at $12.80 ($46,631)
- 4 Open-market sale Chief Scientific Officer sold 4,087 shares at $12.80 ($52,300)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 10,750 shares (option exercise)
- 4 Planned sale Chief Financial Officer sold 5,402 shares at $11.03 ($59,598)
- 4 Open-market sale Chief Financial Officer sold 4,304 shares at $12.01 ($51,695)
- 4 Open-market sale Chief Legal Officer sold 3,841 shares at $12.01 ($46,134)
Page 3 of 14 · 274 filings